Target Price | $384.20 |
Price | $339.39 |
Potential | 13.20% |
Number of Estimates | 35 |
35 Analysts have issued a price target Visa 2026 . The average Visa target price is $384.20. This is 13.20% higher than the current stock price. The highest price target is $410.00 20.80% , the lowest is $310.00 8.66% . | |
A rating was issued by 43 analysts: 33 Analysts recommend Visa to buy, 8 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2026 of 13.20% . Most analysts recommend the Visa stock at Purchase. |
33 Analysts have issued a sales forecast Visa 2025 . The average Visa sales estimate is $39.6b . This is 7.55% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $40.0b 8.80% , the lowest is $39.2b 6.51% .
This results in the following potential growth metrics:
2024 | $35.9b | 10.02% |
---|---|---|
2025 | $39.6b | 10.18% |
2026 | $43.7b | 10.40% |
2027 | $47.9b | 9.57% |
2028 | $54.0b | 12.84% |
25 Analysts have issued an Visa EBITDA forecast 2025. The average Visa EBITDA estimate is $27.9b . This is 8.24% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $29.3b 13.76% , the lowest is $27.3b 5.96% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $25.2b | 9.73% |
---|---|---|
2025 | $27.9b | 10.68% |
2026 | $30.9b | 10.95% |
2027 | $34.1b | 10.29% |
2028 | $38.2b | 11.97% |
2024 | 70.13% | 0.26% |
---|---|---|
2025 | 70.45% | 0.46% |
2026 | 70.80% | 0.50% |
2027 | 71.27% | 0.66% |
2028 | 70.71% | 0.79% |
21 Visa Analysts have issued a net profit forecast 2025. The average Visa net profit estimate is $21.7b . This is 13.44% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $22.2b 16.14% , the lowest is $21.1b 10.42% .
This results in the following potential growth metrics and future Net Margins:
2024 | $18.7b | 17.67% |
---|---|---|
2025 | $21.7b | 15.80% |
2026 | $24.8b | 14.29% |
2027 | $28.1b | 13.10% |
2028 | $33.2b | 18.15% |
2024 | 52.19% | 6.95% |
---|---|---|
2025 | 54.85% | 5.10% |
2026 | 56.78% | 3.52% |
2027 | 58.61% | 3.22% |
2028 | 61.37% | 4.71% |
21 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is $11.11 . This is 13.48% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.37 16.14% , the lowest is $10.81 10.42% .
This results in the following potential growth metrics and future valuations:
2024 | $9.59 | 17.67% |
---|---|---|
2025 | $11.11 | 15.85% |
2026 | $12.69 | 14.22% |
2027 | $14.36 | 13.16% |
2028 | $16.96 | 18.11% |
Current | 34.67 | 6.25% |
---|---|---|
2025 | 30.56 | 11.85% |
2026 | 26.74 | 12.50% |
2027 | 23.64 | 11.59% |
2028 | 20.01 | 15.36% |
Based on analysts' sales estimates for 2025, the Visa stock is valued at an EV/Sales of 16.83 and an P/S ratio of 16.75 .
This results in the following potential growth metrics and future valuations:
Current | 18.10 | 7.48% |
---|---|---|
2025 | 16.83 | 7.02% |
2026 | 15.24 | 9.42% |
2027 | 13.91 | 8.73% |
2028 | 12.33 | 11.38% |
Current | 18.02 | 7.17% |
---|---|---|
2025 | 16.75 | 7.02% |
2026 | 15.17 | 9.42% |
2027 | 13.85 | 8.73% |
2028 | 12.27 | 11.38% |
Analyst | Rating | Action | Date |
---|---|---|---|
Susquehanna |
Positive
➜
Positive
|
Unchanged | Feb 21 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 03 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Jan 31 2025 |
B of A Securities |
Neutral
➜
Neutral
|
Unchanged | Jan 31 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jan 31 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jan 31 2025 |
Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | Jan 31 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Susquehanna:
Positive
➜
Positive
|
Feb 21 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 03 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Jan 31 2025 |
Unchanged
B of A Securities:
Neutral
➜
Neutral
|
Jan 31 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jan 31 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jan 31 2025 |
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
Jan 31 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.